Cyprotex Company Profile

12:46 EST 17th November 2017 | BioPortfolio

Cyprotex, founded in April 1999, became an independent privately owned company in June 2000 and we were admitted onto the Alternative Investment Market of the London Stock Exchange in February 2002 (CRX).

We are dedicated to the application of pharmacokinetic optimisation in drug discovery to aid effective decision making in the design of compound libraries; rapid lead optimisation; the selection of the optimum candidates for exploratory drug development.


15 Beech Lane
SK10 2DR
United Kingdom


Phone: +44(0) 1625 505 100
Fax: +44(0) 1625 505 199

News Articles [9 Associated News Articles listed on BioPortfolio]

Cyprotex opens new US lab

Macclesfield-based Cyprotex, which provides outsourced services to pharmaceutical companies, has expanded in the US.The company, a specialist in ADME (absorption, distribution, metabolism, and excre...

Cyprotex Breaks Through with 3D Microtissues

Drug analysis specialist Cyprotex has launched a new “in vitro” service which is able to accurately identify drugs which cause structural damage to the heart.It service combines state of...

Cyprotex invests for new markets at Alderley Park

Cyprotex, the Macclesfield-based drug analysis specialist, is investing in its new space at the BioHub at Alderley Park.In a stock market statement it said it was expanding its bioanalytical capabil...

Cyprotex to Expand Cosmetics Testing with US Deal

Cyprotex, the drug analysis specialist, is paying around £650,000 for CeeTox which carries out toxicology tests on cosmetics and other personal care products.The US-based business is being acq...

Record year for Cyprotex

Contract research organisation Cyprotex has hailed a record year with turnover nearing the £10m-mark.The Macclesfield-based business has posted revenue of £9.8m for the year to 31 Decembe...

US acquisition for Cyprotex

Macclesfield-based Cyprotex has acquired a business in the US. The contract research organisation has purchased the business and assets of CeeTox Inc, a division of North American Science Associates ...

Cyprotex returns to operational profit

Macclesfield-headquartered drug researcher Cyprotex has returned to operational profit following a significant investment in its testing services in 2014. The company, which specialises in research ...

Evotec announces its intent to acquire Cyprotex PLC

Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that it has made an offer to acquire Cyprotex PLC ("Cyprotex", AIM: CRX-GB), a specialist pre-clinical contract re...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]


Cyprotex, founded in April 1999, became an independent privately owned company in June 2000 and we were admitted onto the Alternative Investment Market of the London Stock Exchange in February 2002 (C...

Cyprotex PLC

Cyprotex Discovery Ltd

More Information about "Cyprotex" on BioPortfolio

We have published hundreds of Cyprotex news stories on BioPortfolio along with dozens of Cyprotex Clinical Trials and PubMed Articles about Cyprotex for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cyprotex Companies in our database. You can also find out about relevant Cyprotex Drugs and Medications on this site too.

Quick Search

Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Corporate Database Quicklinks

Searches Linking to this Company Record